Skip to main content

Imane Boutitah Benyaich

Institutions of which they are part

Predoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Imane Boutitah Benyaich

Institutions of which they are part

Predoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Projects

Caracterización de las infecciones y de su impacto en pacientes con Esclerosis Múltiple en la era de los tratamientos inmunosupresores de alta eficacia

IP: Susana Otero Romero
Collaborators: Imane Boutitah Benyaich, Blanca Borras Bermejo, Anna Falcó Roget, Mar Tintore Subirana, Ana Zabalza de Torres, Jesus Trejo Zahinos, Enrique Rodríguez Zafra
Funding agency: Instituto de Salud Carlos III
Funding: 115000
Reference: PI23/01654
Duration: 01/01/2024 - 31/12/2026

Related news

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

The session has helped bring the public an up-to-date perspective on diagnosis, treatments, and the research lines that are transforming the future of patients.

Dr. Xavier Montalban, Dr. Álex Rovira, Dr. Mar Tintoré and Dr. Jaume Sastre Garriga have been recognised in the listing.

Related professionals

Ana Sarrias Gimenez

Ana Sarrias Gimenez

Postdoctoral researcher
Biomedical Research in Urology
Read more
Catherin Juliette Manrique Sarmiento

Catherin Juliette Manrique Sarmiento

Personal de manteniment i serveis generals
General Services and Infrastructures Unit
Infrastructure Coordination
Manager
Read more
Dinara Samarkanova

Dinara Samarkanova

Main researcher
Transfusional Medicine
Read more
Carmen Pastor Quiñones

Carmen Pastor Quiñones

Research technician
Musculoskeletal Tissue Engineering
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.